Perioperative medicine & outcomes

Perioperative copeptin: predictive value and risk stratification in patients undergoing major noncardiac surgery—a prospective observational cohort study

Can J AnaesthPublished Prospective observational cohort study

Authors' conclusion

The results of the present prospective observational cohort study suggest that perioperative copeptin concentrations can help identify patients at risk for all-cause mortality and/or MACCE.

Study context

Population
Adults undergoing noncardiac surgery with intermediate to high surgical risk, Basel (Switzerland) and Düsseldorf (Germany), 2016–2020
Participants
502 adults
Exposure
Elevated vs non-elevated perioperative copeptin
Outcome
Composite of:
  • All-cause mortality
  • MACCE
Follow-up
12 months
Methodological detailsmulticentre
  • Multicentre

Main finding

As reported in the abstract

All-cause mortality and/or MACCE
Hazard ratio (95% CI)
Elevated preoperative copeptinassociation persisted in multivariable analysis
2.89(1.62–5.2)
Elevated immediate postoperative copeptin
2.07(1.17–3.66)
Elevated copeptin on POD 2-4association persisted in multivariable analysis
2.47(1.36–4.46)
Primary outcome event
48/502 (9.6%)

Observational data: associations, not effects.

Further findings

30-day major adverse cardiac and cerebrovascular events (MACCE) (elevated copeptin on POD 2-4)

HR for MACCE (95% CI)
Elevated copeptin on POD 2-4Reported as association with 30-day MACCE-free survival2.15 (1.18–3.91)

Death and/or MACCE at 12 months, multivariable analysis

Association persisted for preoperative copeptin and copeptin on POD 2-4

Perioperative myocardial injury (PMI)

PMI
64 of 489 (13.1%)
Elevated preoperative copeptin not associated with PMI; immediate postoperative copeptin modestly associated

Original publication

Perioperative copeptin: predictive value and risk stratification in patients undergoing major noncardiac surgery—a prospective observational cohort study. Can J Anaesth. Published 19 January 2024. doi:10.1007/s12630-023-02677-y

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.